Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wells Fargo Downgrades NeuroPace to Equal-Weight, Announces $11 Price Target

Wells Fargo analyst Lawrence Biegelsen downgrades NeuroPace (NASDAQ:NPCE) from Overweight to Equal-Weight and announces $11 price target.

byBenzinga Newsdesk

January 19, 2022

1 minute read

Wells Fargo analyst Lawrence Biegelsen downgrades NeuroPace (NASDAQ:NPCE) from Overweight to Equal-Weight and announces $11 price target.

Keybanc Maintains Overweight on CenterPoint Energy, Raises Price Target to $29

By Benzinga Newsdesk

Today, 2:54 AM

Keybanc maintains CenterPoint Energy (NYSE:CNP) with a Overweight and raises the price target from $28 to $29.

CNP

News

Visa Expects Non-GAAP Operating Expenses In Constant Dollars To Grow In The Mid-Teens

By Michael Horton

Today, 2:54 AM

-Reuters

Peloton To Roll Out New Pricing Model: What You Need To Know

By Adam Eckert

Today, 2:54 AM

Peloton Interactive Inc (NASDAQ: PTON) CEO Barry McCarthy took over as chief executive officer last month and immediately went to work following months of downward price a

PTON

Needham Maintains Buy on Veeva Systems, Raises Price Target to $385

By Benzinga Newsdesk

Today, 2:54 AM

Needham analyst Ryan MacDonald maintains Veeva Systems (NYSE:VEEV) with a Buy and raises the price target from $336 to $385.

VEEV

Wells Fargo Downgrades NeuroPace to Equal-Weight, Announces $11 Price Target

Related Posts

Keybanc Maintains Overweight on CenterPoint Energy, Raises Price Target to $29

Visa Expects Non-GAAP Operating Expenses In Constant Dollars To Grow In The Mid-Teens

Peloton To Roll Out New Pricing Model: What You Need To Know

Needham Maintains Buy on Veeva Systems, Raises Price Target to $385